NDA 208232 Orphan Drug Designation Letter for Mycapssa (6/17/10)

Contents: Orphan drug designation letter for Mycapssa (Octreotide), dated June 17, 2010.

New Drug Application (NDA): 208232
Company: CHIESI
Drug Name: MYCAPSSA
Active Ingredients: OCTREOTIDE ACETATE
Strength: EQ 20MG BASE
Dosage Form/Route: CAPSULE, DELAYED RELEASE;ORAL
Marketing Status:  Prescription

PUBLICLY AVAILABLE (we charge a convenience fee for download)